SCHEMBL21936231

SCHEMBL21936231

C=Cc1cc(N=N)c(NCC(C)(C)O)c(C(F)F)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18911898 0.84 — —
SCHEMBL21936240 0.83 — —
SCHEMBL21936204 0.69 IL1B (0.32) —
SCHEMBL18911975 0.69 IL1B (0.30) —
SCHEMBL21937323 0.69 — —
SCHEMBL21936752 0.68 — —
SCHEMBL21936235 0.67 IL1B (0.30) —
SCHEMBL21936811 0.67 — —
SCHEMBL21937310 0.66 — —
SCHEMBL18911893 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
Send feedback